Shares of Tricida, Inc. (TCDA) have traded between $18.03 – 44.3. The next earnings date is set for May 13, 2020. Let’s see how its prospects are shaping up.

What does Tricida, Inc.(TCDA) do?

Tricida, Inc. is a pharmaceutical company. It focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker in 2013 and is headquartered in South San Francisco, CA.

TCDA Insider Trading Insight

On 2020-03-16, Klaerner Gerrit Pres, CEO sold 4,000 shares of TCDA. That represents a value of $604,644. Not to be outdone, on 2020-03-10, Parker Geoffrey M. P – Purchase bought5,000 shares of TCDA. These insiders are clearly in the know because they work closely with the company.

FL Intraday Trading

FL is due to report earnings on May 22, 2020. In the last year the price has ranged from 20.3 – 65.05. Recently, Johnson Richard A sold 80,000 shares of FL. He is a $283,723 shareholder in FL.